Published Date
Date:
Author
Abstract
Since the 1980s, Malaysia has enthusiastically worked on the development of genetically modified (GM) crops. However, with certain barriers and hindrance, the successful development seems unattainable. This paper explores the critical factors and issues which affect the successful commercialisation of GM crops in Malaysia. Six major factors such as the human capital and other capital requirement, biosafety regulation, institutional roles, intellectual property (IP) protection, technical constraints and public acceptance were investigated using face-to-face and telephone interview which involved ten respondents from several institutions. The data was analysed using NVivo computer software version 2.0. According to the results of the research, the most crucial factors were human capital, other capital requirement and institutional roles. A combination model was constructed using the dimension of the six factors and the development model of agro-based product by Monsanto.
References
For further details log on website :
http://link.springer.com/chapter/10.1007/978-981-287-077-3_86
Date:
Author
Abstract
Since the 1980s, Malaysia has enthusiastically worked on the development of genetically modified (GM) crops. However, with certain barriers and hindrance, the successful development seems unattainable. This paper explores the critical factors and issues which affect the successful commercialisation of GM crops in Malaysia. Six major factors such as the human capital and other capital requirement, biosafety regulation, institutional roles, intellectual property (IP) protection, technical constraints and public acceptance were investigated using face-to-face and telephone interview which involved ten respondents from several institutions. The data was analysed using NVivo computer software version 2.0. According to the results of the research, the most crucial factors were human capital, other capital requirement and institutional roles. A combination model was constructed using the dimension of the six factors and the development model of agro-based product by Monsanto.
References
- 1.Brooker, R. J. (2005). Genetics analysis and principles (2nd ed.). New York: McGraw-Hill companies, Inc.
- 2.Ellis, G. C. (2006). Report on the status of agricultural biotechnology, R&D and intellectual property in Malaysia and Thailand 2006. CIPP&PIPRA Rep. 36pp.
- 3.Taylor, N., Kent, L., & Fauquet, C. (2004). Progress and challenges for the deployment of transgenic technologies in cassava. AgBioforum, 7(1&2), 51–56.
- 4.Ozor, N. (2008). Challenges and impacts of agricultural biotechnology on developing societies. African Journal of Biotechnology, 7(4), 322–330.
- 5.Idris, S. H. (2008). Bio safety law: Does it really protect the environment? International conference on environmental research and technology (ICERT) 2008, Penang, pp. 297–302.
- 6.Kalaitzandonakes, N., Alston, J., & Bradford, K. (2007). Measuring the costs of biosafety regulation and the potential impacts on biotechnology research and development. 9th internal symposium on the biosafety of genetically modified organisms, Jeju Island, 24–29 Sept 2006, pp. 173–178.
- 7.Zhong, F., Marchant, M. A., Ding, Y., & Lu, K. (2002). GM foods: Nanjing case study of Chinese consumers’ awareness and potential attitudes. AgBioforum, 5(4), 136–144.
- 8.Wen, Y. K (2006). The road to commercialization of transgenic products in Taiwan-A bridge too far. International symposium on ecological and environmental of biosafety of transgenic plants, Syngenta, pp. 193–210.
- 9.Abu Bakar, U. K. (2007). Commercialization of biotech crop in Asia course: Benefits to MARDI and Malaysia. High level policy dialogue on agriculture biotechnology, Canberra, 20–21 Jan 2007, pp. 1–8.
- 10.Monsanto. (2009). Understand the pipeline. Retrieved Aug 30, 2009, from http://www.monsanto.com/
For further details log on website :
http://link.springer.com/chapter/10.1007/978-981-287-077-3_86
No comments:
Post a Comment